Evidence map›Paper›PMID 41802785›Full record

SynthesisBMJ open2026

Organ failure type in fatal and near-fatal anaphylaxis: a systematic review.

Ben McKenzie, Stuart D Marshall, Lena Sanci, Jasmine Poonian, Rishabh Nair, Chris J Selman, Jo A Douglass

Abstract readSystematic Review
In one paragraph

Synthesis in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ben McKenzieMedicine, The University of Melbourne Melbourne Medical School, Melbourne, Victoria, Australia ben.mckenzie@unimelb.edu.au.ORCID http://orcid.org/0009-0001-2856-2609
Stuart D MarshallCritical Care, The University of Melbourne Melbourne Medical School, Melbourne, Victoria, Australia.
Lena SanciGeneral Practice and Primary Care, The University of Melbourne Melbourne Medical School, Melbourne, Victoria, Australia.
Jasmine PoonianEmergency Medicine, The Royal Melbourne Hospital City Campus, Melbourne, Victoria, Australia.
Rishabh NairEmergency Medicine, The Royal Melbourne Hospital City Campus, Melbourne, Victoria, Australia.
Chris J SelmanCritical Care, The University of Melbourne Melbourne Medical School, Melbourne, Victoria, Australia.
Jo A DouglassMedicine, The University of Melbourne Melbourne Medical School, Melbourne, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAnaphylaxis is a sudden onset multiorgan allergic reaction that infrequently but regularly causes fatalities which may be preventable with appropriate organ support. There is limited data about the type of organ failure leading to death or near-fatal episodes resulting in permanent neurological disability. To assist clinicians facing anaphylaxis in diverse clinical settings, we aimed to quantify the frequency of organ failure type contributing to death or neurological disability from anaphylaxis according to allergen trigger.

designSystematic review of published peer-reviewed literature. DATA SOURCES: Three databases were searched to January 2025: MEDLINE from 1946, Embase from 1947 and Web of Science from 1900. ELIGIBILITY CRITERIA: Studies were eligible if they contained data about the type of clinical deterioration during anaphylaxis resulting in death or permanent neurological disability. No language restriction was implemented. Exclusion criteria were: hydatid anaphylaxis; five or more stings from an insect; death from acute atheromatous myocardial infarction and where anaphylaxis was only a differential diagnosis. DATA EXTRACTION AND SYNTHESIS: We extracted information using pre-specified criteria to determine the primary organ failure involved: either upper airway obstruction, lower respiratory obstruction (bronchospasm) or cardiovascular failure. Baseline demographics including age and asthma status were collected along with the allergen trigger, time course and treatment. We reported frequencies according to allergen trigger for case reports and a narrative analysis of case series weighted by risk of bias assessment.

results277 case studies and 14 case series were identified reporting 896 deaths and 28 disabilities. There were no other study types. Separate case series and case report analyses produced similar findings despite varying quality of published clinical data. Respiratory failure was the most common primary organ failure in case reports (73.4%), whereas primary cardiovascular failure was reported in 26.6% of case reports. Primary organ failure type differed in frequency by allergen trigger and was primarily caused by: respiratory failure when food was the allergen trigger (95%); respiratory failure in 65% of cases of drug allergen triggers; cardiovascular failure in 65% venom allergen triggers.

conclusionIn this review, respiratory failure (primarily bronchospasm) is the most common primary physiological event leading to decompensation in fatal anaphylaxis, particularly for food and drug allergen deaths. Emphasising the significance of respiratory involvement, particularly from bronchospasm, in both patient and clinician facing anaphylaxis treatment guidelines may help further reduce the risk of fatalities. Prospective anaphylaxis management registries or whole population data are needed to better capture primary organ failure present in fatal anaphylaxis to validate this finding. PROSPERO REGISTRATION NUMBER: CRD42023434206.

Indexed as

AnaphylaxisMultiple Organ FailureAllergensBronchial SpasmHumansRespiratory InsufficiencyAllergensACCIDENT & EMERGENCY MEDICINEAllergyANAESTHETICSAsthmaINTENSIVE & CRITICAL CAREPaediatric intensive & critical care

Identifiers

PMID41802785
PMCPMC12983974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.